SCHEMBL23569271

SCHEMBL23569271

N[S@+]([O-])c1cccc(Cl)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.41
TSHR P16473 4/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 2/20 0.38
TAAR1 Q96RJ0 2/20 0.38
CYP3A4 P08684 1/20 0.38
NFKB1 P19838 1/20 0.38
IDO1 P14902 2/20 0.36
LMNA P02545 2/20 0.36
ALDH1A1 P00352 2/20 0.36
GLA P06280 1/20 0.36
CYP2A6 P11509 1/20 0.35
MAOA P21397 1/20 0.34
MAPK1 P28482 1/20 0.34
ADRA1A P35348 1/20 0.34
SCN4A P35499 1/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34
PDE3A Q14432 1/20 0.34
SCN5A Q14524 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23568725 1.00 PNMT (0.41) PNMTTSHRCYP1A2CYP2D6TAAR1
SCHEMBL9846801 0.83 TSHR (0.45) PNMTTSHRCYP1A2TAAR1IDO1
SCHEMBL9846799 0.83 TSHR (0.45) PNMTTSHRCYP1A2TAAR1IDO1
SCHEMBL6908412 0.81 TSHR (0.42) PNMTTSHRCYP1A2CYP2D6TAAR1
SCHEMBL23569368 0.78 NR4A2 (0.34) PNMTTSHRCYP1A2TAAR1IDO1
SCHEMBL23531754 0.78 NR4A2 (0.34) PNMTTSHRCYP1A2TAAR1IDO1
SCHEMBL15340796 0.77 TSHR (0.39) PNMTTSHRCYP1A2CYP2D6TAAR1
SCHEMBL11293986 0.73 CYP1A2 (0.39) PNMTTSHRCYP1A2CYP2D6TAAR1
SCHEMBL4632092 0.72 TSHR (0.35) PNMTTSHRCYP1A2CYP2D6TAAR1
SCHEMBL3645067 0.71 TSHR (0.58) PNMTTSHRCYP1A2CYP2D6TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021123237-A1 2-AMINO-N-(AMINO-OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE Oxford Drug Design Limited (GB) 2021-06-24 WO disclosed